Dear stumpedNSJ,
Large granular lymphocytes (LGLs) are lymphocytes with a size larger than that of the normal lymphocytes and contain azurophilic cytoplasmic granules. LGLs are classified phenotypically (cell membrane markers) into Natural killer NK cell or T-cell phenotype.
There are four lymphoproliferative disorders affecting LGLs:
reactive/transient LGL expansion,
chronic LGL lymphocytosis,
indolent LGL
leukemia, and
aggressive LGL
leukemia.
80% of LGL
leukemia are due to clonal expansion of the T-cell phenotype. The T-cell variant of
chronic lymphocytic leukemia CLL represents 25% of all
CLL cases.
Different viruses have been implicated in the pathogenesis of LGL
leukemia like: Human T-cell
leukemia-
lymphoma virus-I-II (HTLV I-II), Epstein-Barr virus (
EBV), Human immunodeficiency virus (
HIV) and Human Herpes virus type-8 (HHV8). However no direct relation between the infection with any of these viruses and the development of T-LGL
leukemia.
Any case of unexplained cytopenias and high numbers of LGLs should be investigated for LGL
leukemia.
Laboratory investigation: complete blood picture
CBC and blood smear show any of the following:
Neutropenia in almost 85% of cases (counts of 500/µl in 50% of patients).
Anemia in 50% of the cases.
Moderate thrombocytopenia in 20% of them.
The peripheral blood smear:
A normal lymphocytic count or a mild lymphocytosis ( 7,800/µl).
Increased number of the circulating granular lymphocytes up to 4,000/µl (N. 223 ± 99/µl).
Criteria for diagnosis of LGL
leukemia:
Abnormal monoclonal proliferation of CD8+ T cells in patients with cytopenia.
Clonality is measured by gene rearrangement studies using Southern blotting or by polymerase chain reaction (PCR) on the DNA extracted from the proliferating large lymphocytes. PCR is the most commonly used for its convenience. Flow cytometry analysis is another procedure that can be also used.
The classic immunophenotype of the malignant T cell in LGL
leukemia is CD3+CD4–CD8+CD16+CD27– CD45R0–CD57+CD94+.
Atypical lymphocytosis occurs in many conditions that should be excluded before the diagnosis of LGL
leukemia.
The majority of these causes are viral infections.
In Epstein-Barr virus (
EBV) infection the atypical lymphocytes are not CD57+.
In
Cytomegalovirus infection in spite the mild increase in CD3+, CD57+ LGL; there is no evidence for TCR gene rearrangement.
In Human immunodeficiency virus infection, the LGL are polyclonally expanded.
A common association between LGL
leukemia and other systemic diseases is common and include:
Autoimmune diseases, e.g.
rheumatoid arthritis RA , Felty's syndrome
Hematologic disorders including, autoimmune thrombocytopenia, autoimmune hemolytic
anemia, and
Other malignancies such as
myelodysplasia and B-cell lymphoproliferative disorders.
Natural History, Prognosis, and Therapy of LGL
Leukemia:
LGL
leukemia is an indolent chronic disorder. Some patients with mild cytopenias and/or lymphocytosis remain asymptomatic for a long period. Spontaneous remissions have been reported in some studies.
In symptomatic cases (majority) treatment should be initiated. Being a rare malignancy, treatment recommendations are based on data coming from case reports and retrospective studies. Recurrent neutropenia and infections are the main concern in treatment of this disease.
Treatments for symptomatic cases include:
Growth factors:
Both G-CSF and GM-CSF are effective in the treatment of severe infections with netropenia
Immunosuppressive agents are used in patients with both neutropenia and
anemia, they include
Methotrexate,
Cyclophosphamide, and
Cyclosporine
All of them have been used alone or in combination with prednisone.
Prednisone alone produced clinical improvement in neutropenia.
Fludarabine and pentostatin have been shown to induce clinical and not cytogenetic remission.
I hope you find this information helpful
Best regards,
This answer does not substitute for direct medical consultation.
Dr. Safaa Mahmoud.
MB BCh, MSc Internal Medicine. MD Medical Oncology.
PhD Experimental Medicine and Biochemical Science.